CRISPR/Cas9 Therapy For Androgenic Alopecia: Moogene Medi - Follicle Thought
Moogene Medi of South Korea is the first company to formally introduce a CRISPR-based gene editing hair loss therapy to the world. Description Of CRISPR Therapy For Androgenetic Alopecia Moogene has developed a microbubble-nanoliposomal delivery system to get gene editing particles directly into the dermal...
www.folliclethought.com
Some biotech companies are researching the use of crispr to battle hair loss, this is one of them and the article says it will be used to suppress the gene that makes the enzyme 5 alpha reductase. Seems like it could work